23andMe's designer baby patent

@article{Defrancesco201423andMesDB,
  title={23andMe's designer baby patent},
  author={Laura Defrancesco},
  journal={Nature Biotechnology},
  year={2014},
  volume={32},
  pages={8-8}
}
  • L. Defrancesco
  • Published 9 January 2014
  • Engineering, Medicine
  • Nature Biotechnology

From Self‐Determination to Offspring‐Determination? Reproductive Autonomy, Procrustean Parenting, and Genetic Enhancement

Emerging reprogenetic technologies may radically change how humans reproduce in the not-so-distant future. One foreseeable consequence of disruptive innovations in the procreative domain is an

Highly Conductive Graphene Electronics by Inkjet Printing

Abstract Graphene is currently emerging as an alternative to traditional conductive materials, such as copper and silver because of its excellent electrical conductivity and earth's carbon abundance.

Evolution, Human Enhancement, and Human Nature: Four Challenges to Essentialism in Theological Anthropology

The Christian theological tradition has been predominantly essentialist: it has held that creation is ordered by God’s providential work into natural kinds, and that each kind exemplifies a nature

Valuing Reprogenetic Technologies: Bringing Insights from the Philosophy of Technology to Bioethics

Reprogenetic technologies have been enthusiastically embraced by well-known authors who argue that these technologies increase reproductive choice, contribute to a reduction of suffering by

Nunes Human Genetic Intervention : How Far Should We Go ?

Organ Bioprinting: Are We There Yet?

TLDR
A convergence of these areas into a systemic research area “3D bioprinting” is needed to develop biopprinting as a viable approach for creating fully functional organs for standard clinical diagnosis and treatment including transplantation.

The morality of patents on pre-implantation genetic diagnosis

TLDR
These two hybrid models could be useful for banks to collect cord blood and increase its use in allogeneic transplantation in countries without a government-funded cord blood donation program with private funding.